SCHEMBL4363783

SCHEMBL4363783

COC(=O)c1sc(-c2ccccc2)cc1S(N)(=O)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.58
KDM4E B2RXH2 6/20 0.58
ALDH1A1 P00352 4/20 0.58
LMNA P02545 2/20 0.58
HPGD P15428 4/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
GAA P10253 1/20 0.55
HTT P42858 1/20 0.52
ATM Q13315 1/20 0.52
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA5A P35218 1/20 0.50
CA9 Q16790 1/20 0.50
TP53 P04637 2/20 0.49
POLB P06746 1/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
IKBKB O14920 2/20 0.49
CASP3 P42574 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4360547 0.86 MAPT (0.58) MAPTKDM4EALDH1A1LMNAHPGD
SCHEMBL318949 0.82 MAPT (0.63) MAPTKDM4EALDH1A1LMNAHPGD
SCHEMBL9825984 0.81 MAPT (0.65) MAPTKDM4EALDH1A1LMNAHPGD
SCHEMBL431794 0.80 MAPT (0.74) MAPTKDM4EALDH1A1LMNAHPGD
Hydrochloric Acid SCHEMBL8864118 0.78 MAPT (0.72) MAPTKDM4EALDH1A1LMNAHPGD
SCHEMBL9975800 0.78 MAPT (0.62) MAPTKDM4EALDH1A1LMNAHPGD
SCHEMBL977550 0.78 MAPT (0.65) MAPTKDM4EALDH1A1LMNAHPGD
SCHEMBL1724059 0.78 MAPT (0.65) MAPTKDM4EALDH1A1LMNAHPGD
SCHEMBL2158104 0.77 HPGD (0.64) MAPTKDM4EALDH1A1LMNAHPGD
SCHEMBL13355827 0.77 MAPT (0.63) MAPTKDM4EALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090192154-A1 SULTAM DERIVATIVES ASAHI KASEI PHARMA CORPORATION (JP) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192154-A1 SULTAM DERIVATIVES SULT1A1, SULT2A1, ADAMTS1 MAPT 948/4885KDM4E 4056/4885ALDH1A1 187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.